FGP
BRKR icon

Freestone Grove Partners’s Bruker BRKR Stock Holding History

Freestone Grove Partners’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-685,927
Closed -$32.3M – 1000
2025
Q4 		$32.3M Buy
685,927
+204,006
+42% +$8.62M 0.23% 140
2025
Q3 		$15.7M Buy
+481,921
New +$17.2M 0.12% 240

Other funds holding BRKR

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Freestone Grove Partners's BRKR Position: Q1 2026 in Review

Freestone Grove Partners sold out of Bruker (BRKR) in Q1 2026, closing a stake of 685,927 shares — an estimated $32.3M sold.

Freestone Grove Partners first reported a position in BRKR in Q3 2025 and held it in 2 quarters. The position peaked at $32.3M in Q4 2025. 342 funds tracked by Wall St. Rank hold BRKR as of Q1 2026.

  • Freestone Grove Partners reported no remaining Bruker position as of Q1 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 685,927 Bruker shares in Q1 2026, an estimated $32.3M.
  • Freestone Grove Partners first reported a position in Bruker in Q3 2025 and held it in 2 quarters.
  • Freestone Grove Partners's Bruker position peaked at $32.3M in Q4 2025.
  • 342 funds tracked by Wall St. Rank held Bruker as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.